Mkts

Korro Bio, Inc.

NASDAQ: KRRO
$12.44+0.12 (+0.97%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
11.8513.34
52-week range
5.2017.35
Today
Open12.19
Previous close12.44
Volume—
Valuation
Market cap173.90M
P/E ratio—
EPS (TTM)-9.06
Income & risk
Dividend / yield—
Beta3.27
Avg volume169.3K
Discussion

KRRO News

Stories mentioning KRRO from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.001,2921,0901,4602,5502,2710.000.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development12,95110,98513,82021,03119,73916,96215,96417,138
Sales General & Admin
Total Operating Expenses20,43651,68820,32728,66227,57025,31123,29224,125
Operating Income (Loss)(20,436)(50,396)(19,237)(27,202)(25,020)(23,040)(23,292)(24,125)
Interest Income
Interest Expense
Other Expense906.00990.001,1761,4331,6331,9442,2842,329
Pretax Income(19,530)(49,406)(18,061)(25,769)(23,387)(21,096)(21,008)(21,796)
Tax Provision95.00636.000.001.000.00103.00(9.00)30.00
Net Income (Loss)(19,625)(50,042)(18,061)(25,770)(23,387)(21,199)(20,999)(21,826)
Earnings Per Share (Basic)(1.69)(5.33)(1.92)(2.74)(2.49)(2.38)(2.26)(2.43)
Earnings Per Share (Diluted)(1.69)(5.33)(1.92)(2.74)(2.49)(2.38)(2.26)(2.43)
Weighted Average Shares Outstanding (Basic)11,5999,3959,3929,3919,3848,9219,3038,987
Weighted Average Shares Outstanding (Diluted)11,5999,3959,3929,3919,3848,9219,3038,987

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About KRRO

Korro Bio, Inc. (NASDAQ: KRRO) is a stock listed on the Nasdaq Stock Market under the ticker symbol KRRO. It last traded at $12.44 (Nov 18, 2026, 4:00 PM ET), up 1.0% on the day. That gives Korro Bio a market capitalisation of $173.9M.

Over the past 52 weeks KRRO has traded between $5.20 and $17.35.

Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $19.6M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$0-$19.6M—
Dec 31, 2025$1.3M-$50.0M-3873.2%
Sep 30, 2025$1.1M-$18.1M-1657.0%
Jun 30, 2025$1.5M-$25.8M-1765.1%

From Korro Bio’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…